🎙 Listen to the full episode on Spotify, Apple, and YouTube.
In this episode of Aggaeus, Haggai Klorman Eraqi sits down with Gil Dibner, General Partner of Angular Ventures, for a conversation about venture capital, AI hype, non-consensus founders, fiduciary responsibility, and why the best investments often look strange before they look inevitable.
Gil describes himself as geographically confused: American, Israeli, based in London, investing across Europe and Israel.
That outsider position shaped how he thinks.
He is drawn to outsiders. To founders with something burning inside them. To technologies that do not fit neatly into a hype cycle. To companies where the first reaction might be: “Why would anyone invest in that?”
In a market where venture dollars are concentrating into fewer funds, fewer companies, and bigger AI rounds, Gil argues that the old craft of venture still matters.
But in venture, “simple” is never that. AI has made demos easier, valuations higher, metrics noisier, and consensus more expensive. Gil explains why founders need to understand the difference between real conviction and market heat and why investors need to remember they are managing other people’s money.
In this episode, we cover:
• Why AI has created strange new dynamics in startup funding
• Why too much capital can distort both founders and investors
• What makes a founder “best in class” or truly one of one
• Why Angular looks for non-consensus companies others may overlook
• Why AI adoption may be massive, but still slower and messier than the hype suggests
SPONSORS - EXCLUSIVE FOR AGGAEUS PODCAST LISTENERS:
BUY 2, GET 3 ON KARDZ.BIZ — UP TO $479 VALUE.
AGGAEUSB2G3PREMIUM - for PREMIUM cards
AGGAEUSB2G3PRO+ - for PRO+ cards
When face-to-face impressions matter, pull out Kardz.Biz, the “business card too good to give away”.
Use this link: https://kardz.biz/?ref=yqrmczty
SAVE 10% ON BETTER WEIGHT FOR LIFE’S GLP-1 PROGRAMS WITH CODE AGGAEUS10 (LIMITED TIME).
Better Weight For Life is a transformational weight loss program led by a U.S. board-certified physician designed to keep it simple: personalized GLP-1 treatment, expert support, and discreet delivery.
They offer options including Ozempic®, Wegovy®, Zepbound®, Mounjaro®, plus compounded semaglutide and compounded tirzepatide (eligibility depends on your medical evaluation).
Claim the offer here: https://www.betterweightforlife.com/partners/aggaeus
CONNECT WITH GIL DIBNER
CONNECT WITH HAGGAI
FOLLOW AGGAEUS
INQUIRIES
💼 Sponsorships / Business: talktous@aggaeus.com
🎙 Podcast: DM via Instagram
DISCLAIMER
Some links may earn affiliate commissions. Offers, terms, and availability may change without notice.
Aggaeus content is for informational and educational purposes only and should not be considered legal, business, investment, or tax advice. You should conduct your own research and consult qualified professionals before making any decisions.
We may feature companies, products, or entities in which Aggaeus, its affiliates, or the author have invested or may invest, or with which they have had, have, or may have a financial, professional, or other relationship.
#Venture #AI #Startups #Founders #Investing
